Yip TCF et al. Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B. (Abstract LB-03),Choi J et al. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol. 2019;5:30-6.
Trombose bij kinderen en adolescenten die zijn opgenomen met COVID-19 of MIS-C
sep 2021 | Benigne hematologie, Virale infecties